Search

everythinglearnresearchcommunity

for

Search:↓

Trichothiodystrophy causes unusual hair and developmental issues.

Fluphenazine and iloprost can induce hair growth.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

High-dose methotrexate can cause severe skin and nail issues.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Some alternative treatments for vitiligo show promise but need more research to confirm their safety and effectiveness.

TPA is about 50 times more effective at promoting tumors than MZ.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

FK506 may stimulate hair growth when applied to the skin.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Tofacitinib may help regrow hair in alopecia areata patients.